E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Is there any relationship between Behçet's disease and hepatit C virus?
(Turk J Gastroenterol 1998; 9: 10-13)
The quality of life in hemodialysis patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2009; 20: 243-246)
DOI: 10.4318/tjg.2009.0020
Prevelance and genotyping of hepatitis C virus RNA in Turkish patinets with non-A, non-B liver disease
(Turk J Gastroenterol 1998; 9: 208-212)
Hepatitis B and C virus in West-Central Turkey: Seroprevalence in healthy individuals admitted to a university hospital for routine health checks
(Turk J Gastroenterol 2006; 17: 267-272)
Chronic hepatitis C with mixed cryoglubulinemia: A cade report
(Turk J Gastroenterol 1996; 7: 254-256)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?
(Turk J Gastroenterol 2003; 14: 194-196)
Autoantibodies in chronic viral hepatitis and autoimmune hepatitis
(Turk J Gastroenterol 1997; 8: 381-384)
Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
(Turk J Gastroenterol 2010; 21: 411-415)
DOI: 10.4318/tjg.2010.0128
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Original Article
The impact of hepatitis C virus infection on long-term outcome in renal transplant patients
(Turk J Gastroenterol 2011; 22: 165-170)
DOI: 10.4318/tjg.2011.0236
Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics
(Turk J Gastroenterol 2012; 23: 574-579)
DOI: 10.4318/tjg.2012.0554
Relationship between serum aminotransferase levels and metabolic disorders in northern China
(Turk J Gastroenterol 2012; 23: 699-707)
DOI: 10.4318/tjg.2012.0589
Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease
(Turk J Gastroenterol 2012; 23: 720-726)
DOI: 10.4318/tjg.2012.0489
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study
(Turk J Gastroenterol 2014; 25: 63-68)
DOI: 10.5152/tjg.2014.6233
Relationship between Helicobacter pylori infection and metabolic syndrome
(Turk J Gastroenterol 2015; 26: 468-473)
DOI: 10.5152/tjg.2015.0197
Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency
(Turk J Gastroenterol 2014; 25: 405-410)
DOI: 10.5152/tjg.2014.7083
Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus
(Turk J Gastroenterol 2015; 26: 511-516)
DOI: 10.5152/tjg.2015.15806
Gastrointestinal Tract - Original Article
Is glycogenic acanthosis a predictor of insulin resistance and metabolic syndrome?
(Turk J Gastroenterol 2017; 28: 337-341)
DOI: 10.5152/tjg.2017.17159
Liver - Original Article
Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study
(Turk J Gastroenterol 2019; 30: 266-270)
DOI: 10.5152/tjg.2018.18559
Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus
(Turk J Gastroenterol 2019; 30: 155-162)
DOI: 10.5152/tjg.2018.18237
Evaluation of neck circumference as an easy and reliable predictor for non-alcoholic fatty liver disease
(Turk J Gastroenterol 2019; 30: 163-170)
DOI: 10.5152/tjg.2018.18004
The relationship of alanine aminotransferase to metabolic syndrome in a Korean population
(Turk J Gastroenterol 2018; 29: 52-60)
DOI: 10.5152/tjg.2018.17333
Poster
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis
(Turk J Gastroenterol 2019; 30: 26-28)
DOI: 10.5152/tjg.2019.15
Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels
(Turk J Gastroenterol 2019; 30: 69-69)
DOI: 10.5152/tjg.2019.46
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 09.05.2019